Developers: | First Moscow State Medical University named after I.M. Sechenov (First Moscow State Medical University) |
Date of the premiere of the system: | June 2023 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
2023: Product Announcement
In mid-June 2023, Russian researchers from Sechenov University announced the creation, according to them, of the first device in Russia to diagnose the syndrome of excessive bacterial growth in the human body.
According to Academician of the Russian Academy of Sciences Vladimir Ivashkin, in Russia, a test for assessing the composition of the intestinal microbiome has always been carried out using imported equipment. The creation of the Russian analogue is carried out within the framework of the state program "Priority-2030." By the end of 2023, the device for assessing the composition of the intestinal microbiome will undergo a comparative trial, and then scientists will begin clinical studies in patients with various nosological forms.
As of June 16, 2023, a group of scientists from Moscow State University. M.V. Lomonosov, together with researchers from the Izhevsk Radio Plant and Sechenov University, are working on a project of clinical recommendations for the diagnosis and treatment of excess bacterial growth syndrome. This direction will help not only increase the level of diagnosis of the syndrome, but will also contribute to providing regional offices with a new device.
Bacterial overgrowth syndrome is characterized by increased or impaired microbiota in the small intestine. This leads to a violation of the intestinal barrier, indigestion and a decrease in the absorption of nutrients. Based on the general complaints of patients, medical history and the results of objective tests, it is possible to determine whether a person has this disease or not. However, the most accurate diagnosis is made using a hydrogen breath test. The syndrome is treated by prescribing oral antibiotics for 10-14 days, the spectrum of action of which extends to aerobic and anaerobic intestinal bacteria. In Russia, the syndrome is often called dysbiosis or intestinal dysbiosis, the disease for 2023 is one of the most common problems in medicine.[1]